Medically reviewed by Doru Paul, MD Immunohistochemistry (IHC) is a special test used by pathologists to detect specific ...

While all steps in the IHC protocol affect the quality of the staining outcome, three important factors to consider during initial optimization are primary antibody selection, antigen retrieval, and ...

Enhertu first secured approval in 2019 for patients with high levels of HER2, a protein that promotes cancer cell growth. In ...

Moreover, inForm can provide area object counts or can be used to automatically assess IHC staining levels on a cell-by-cell and sub-cellular basis, providing extremely accurate and sensitive ...

The U.S. Food and Drug Administration has approved AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) ENHERTU ...

The FDA approved trastuzumab deruxtecan for adult patients with unresectable or metastatic HER2-low or HER2-ultralow breast cancer, based on phase 3 DESTINY-Breast06 trial results.

In the 25 years since the company’s launch, she estimates that LSBio has performed IHC testing on more than ... you can very rapidly conclude what’s real staining and what’s not,” says ...

Other services include a wide array of special stains and immunohistochemistry, as well as histomorphometrical analysis of the histology sections. Histomorphometry studies on bones may utilize ...